Business Context and Reporting Period
Company: Baytex Energy Corp.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Three and six months ended June 30, 2026
Filing Date: July 30, 2026
Context: This filing incorporates by reference the Company's Condensed Interim Unaudited Consolidated Financial Statements (Exhibit 99.1) and Management's Discussion and Analysis (Exhibit 99.2) for the periods ended June 30, 2026, and 2025.
Key Financial Metrics
The provided text serves as a cover document and exhibit index. It does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are located in the incorporated Exhibits 99.1 and 99.2, which are not included in the input text.
Material Changes and Operational Highlights
- Production Performance: The Company reported strong performance in the Duvernay and Peavine regions.
- Guidance Update: Production guidance has been raised based on the aforementioned operational performance.
- Corporate Governance: New Board appointments were announced.
- Dividend: A quarterly dividend for October 2026 was declared.
Guidance, Outlook, and Risks
Outlook: Management has increased production guidance, citing strong results from key assets (Duvernay and Peavine).
Dividend Policy: The Company continues its dividend program with a declaration for October 2026.
Risks and Contingencies: The filing text does not provide specific details regarding risks, contingencies, or unusual items; these are expected to be detailed in the incorporated MD&A (Exhibit 99.2).
Investor Verification Checklist
- Verify the specific production volumes and guidance numbers in the July 30, 2026 Press Release (Exhibit 99.3).
- Review the Condensed Interim Unaudited Consolidated Financial Statements (Exhibit 99.1) for actual revenue, net income, and cash flow figures.
- Confirm the exact dividend amount per share and payment date in the Dividend Press Release (Exhibit 99.6).
- Identify the specific individuals appointed to the Board of Directors.
- Examine the MD&A (Exhibit 99.2) for details on the Duvernay and Peavine performance drivers and any updated risk factors.